Over half of Americans aged 18-29 face rising medical debt due to high cost-sharing and limited marketplace insurance access. Regulatory gaps and pending subsidy expirations heighten risks for young adults' insurance affordability.

Medicaid expansion significantly increases buprenorphine prescriptions for opioid treatment, highlighting insurance's role in addressing the opioid crisis and ensuring access to addiction medication.

Congress faces a critical decision on the extension of ACA enhanced premium tax credits, impacting millions of insured Americans and the health insurance marketplace.

Kaiser Family Foundation projects an 18% median rise in ACA exchange premiums for 2026, driven by market consolidation and regulatory dynamics impacting affordability and competition.

The Trump administration expands eligibility for affordable 'copper plans' on ObamaCare exchanges, aiming to reduce premiums and increase insurance coverage nationwide.

Neil Hopper, a UK vascular surgeon, committed insurance fraud by self-amputating his legs, highlighting challenges in medical ethics and insurance fraud detection.

Study finds the 340B Drug Pricing Program contributes to higher Affordable Care Act Silver Plan premiums, affecting insurance costs and subsidies.

In 2025, the FTC settled with MediaAlpha for $45M over deceptive health insurance lead generation, including illegal telemarketing and false government affiliation claims, emphasizing enforcement of consumer protection laws in insurance marketing.

Explore effective strategies for U.S. healthcare professionals to navigate and overcome prior authorization denials, including regulatory context, appeals process insights, and advocacy tools.

SCAN Group launches a multi-media campaign exposing systemic problems in Medicare Advantage insurance, focusing on coverage gaps, patient access issues, and the impact on healthcare costs during Medicare enrollment.